Prescription drug · ANDA
Sodium Phosphates NDC 72572-309
sodium phosphate, monobasic, monohydrate and sodium phosphate, dibasic anhydrous · Sodium phosphate, Monobasic, Monohydrate 276 mg/mL; Sodium phosphate, Dibasic, Anhydrous 142 mg/mL · Injection, Solution · Intravenous · Civica, Inc.
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 72572-309-25 | 72572030925 | 25 VIAL, SINGLE-DOSE in 1 TRAY (72572-309-25) / 5 mL in 1 VIAL, SINGLE-DOSEMarketed from Aug 13, 2025 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Sodium Phosphates
- Generic name (nonproprietary)
- sodium phosphate, monobasic, monohydrate and sodium phosphate, dibasic anhydrous
- Active ingredients
- Sodium phosphate, Monobasic, Monohydrate — 276 mg/mLSodium phosphate, Dibasic, Anhydrous — 142 mg/mL
- Dosage form
- Injection, Solution
- Route
- Intravenous
- Labeler
- Civica, Inc.
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 218314
- Marketing start
- Listing expires
- Identifiers
- Product ID 72572-309_61394c9f-3b69-4b70-abbb-eab5fde32f75SPL ID 61394c9f-3b69-4b70-abbb-eab5fde32f75SPL set ID 8fd901e6-30cb-411a-b820-b9e79625ec7cRxCUI 1872443UNII 593YOG76RN, 22ADO53M6FUPC 0372572309257
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.
- Administration
Drug administration (CPT 96360–96549)
When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.
- NDC on a medical claim
N472572030925followed by a unit qualifier and the quantityPackage 72572-0309-25. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
INDICATIONS AND USAGE Sodium Phosphates Injection, USP, 3 mM P/mL is indicated as a source of phosphorus, for addition to large volume intravenous fluids, to prevent or correct hypophosphatemia in patients with restricted or no oral intake. It is also useful as an additive for preparing specific parenteral fluid formulas when the needs of the patient cannot be met by standard electrolyte or nutrient solutions. The concomitant amount of sodium (Na + 4 mEq/mL) must be calculated into total electrolyte dose of such prepared solutions.
Excerpt only. Read the full label for complete information.
Other NDCs under ANDA 218314
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Sodium Phosphatessodium phosphate, monobasic, monohydrate and sodium phosphate, dibasic anhydrous | Sodium phosphate, Monobasic, Monohydrate 276 mg/mL; Sodium phosphate, Dibasic, Anhydrous 142 mg/mL | Injection, SolutionIntravenous | American Regent, Inc. | 0517-7305 |
| Sodium Phosphatessodium phosphate, monobasic, monohydrate and sodium phosphate, dibasic anhydrous | Sodium phosphate, Monobasic, Monohydrate 276 mg/mL; Sodium phosphate, Dibasic, Anhydrous 142 mg/mL | Injection, SolutionIntravenous | American Regent, Inc. | 0517-7315 |
| Sodium Phosphatessodium phosphate, monobasic, monohydrate and sodium phosphate, dibasic anhydrous | Sodium phosphate, Monobasic, Monohydrate 276 mg/mL; Sodium phosphate, Dibasic, Anhydrous 142 mg/mL | Injection, SolutionIntravenous | American Regent, Inc. | 0517-7350 |